Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
8.09B
Market cap8.09B
Price-Earnings ratio
-59.42
Price-Earnings ratio-59.42
Dividend yield
—
Dividend yield—
Average volume
2.37M
Average volume2.37M
High today
$151.50
High today$151.50
Low today
$122.08
Low today$122.08
Open price
$141.00
Open price$141.00
Volume
3.48M
Volume3.48M
52 Week high
$219.71
52 Week high$219.71
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $123.00, giving the company a market capitalization of 8.09B. It carries a P/E multiple of -59.42.

During the trading session on 2026-11-11, Twist Bioscience(TWST) shares reached a daily high of $151.50 and a low of $122.08. At a current price of $123.00, the stock is +0.8% higher than the low and still -18.8% under the high.

Trading volume for Twist Bioscience(TWST) stock has reached 3.48M, versus its average volume of 2.37M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $219.71 and a low of $23.30.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $219.71 and a low of $23.30.

TWST News

Investing.com 7h
Twist Bioscience faces earnings test as profit path comes into view - Investing.com

...

Twist Bioscience faces earnings test as profit path comes into view - Investing.com
Simply Wall St 9h
Is Twist Bioscience Undervalued After Its New Oncology Research Product Launches?

Twist Bioscience (TWST) just pushed deeper into oncology tools with Twist MRD Express, a custom panel offering aimed at faster, high-throughput personalized mol...

Is Twist Bioscience Undervalued After Its New Oncology Research Product Launches?
Simply Wall St 6d
Should New Cancer Research Tools Require Action From Twist Bioscience Investors?

Twist Bioscience recently introduced Twist MRD Express and Twist Express Screening Antibodies, expanding its synthetic DNA and protein tools for cancer research...

Should New Cancer Research Tools Require Action From Twist Bioscience Investors?

Analyst ratings

69%

of 13 ratings
Buy
69.2%
Hold
23.1%
Sell
7.7%

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.